BeOne Medicines Ltd. Income Tax Expense 2014-2026 | ONC
Beta
What is income tax expense?
Income tax expense is the total amount of income taxes a company owes to federal, state, and foreign governments.
What is BeOne Medicines Ltd.'s current income tax expense?
BeOne Medicines Ltd. (ONC) annual income tax expense for 2025 was $129.9M, a 16.22% increase from 2024. BeOne Medicines Ltd. income tax expense for the quarter ending March 31, 2026 was $31.9M.
What was BeOne Medicines Ltd.'s income tax expense in 2024?
BeOne Medicines Ltd. annual income tax expense for 2024 was $111.8M, a 100.07% increase from 2023.
What was BeOne Medicines Ltd.'s income tax expense in 2023?
BeOne Medicines Ltd. annual income tax expense for 2023 was $55.9M, a 30.61% increase from 2022.
What is BeOne Medicines Ltd.'s 5-year income tax expense CAGR?
BeOne Medicines Ltd. income tax expense grew at a compound annual growth rate (CAGR) of 65.71% from FY2020 to FY2025, going from $10.4M to $129.9M over 5 years.
Income Tax Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+65.7%
FY2020
$10.4M
→
FY2025
$129.9M
141516171819202122232425
5 years selected
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →